Calvopiña, K., Umland, K., Rydzik, A., Hinchliffe, P., Brem, J., Spencer, J., . . . Avison, M. (2016). Sideromimic Modification of Lactivicin Dramatically Increases Potency against Extensively Drug-Resistant Stenotrophomonas maltophilia Clinical Isolates. American Society for Microbiology.
Citación estilo ChicagoCalvopiña, K., K. Umland, A. Rydzik, P. Hinchliffe, J. Brem, J. Spencer, C. Schofield, and M. Avison. Sideromimic Modification of Lactivicin Dramatically Increases Potency Against Extensively Drug-Resistant Stenotrophomonas Maltophilia Clinical Isolates. American Society for Microbiology, 2016.
Cita MLACalvopiña, K., et al. Sideromimic Modification of Lactivicin Dramatically Increases Potency Against Extensively Drug-Resistant Stenotrophomonas Maltophilia Clinical Isolates. American Society for Microbiology, 2016.